CollPlant Biotechnologies Ltd — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/ec974375-9dcc-44a1-9c53-307cffed3363/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-11.5M | 2025-01-01 – 2025-12-31 | evidence 0001213900-26-034393 |
| FY 2024 | $-17.3M | 2024-01-01 – 2024-12-31 | evidence 0001013762-25-002502 |
| FY 2023 | $-7.5M | 2023-01-01 – 2023-12-31 | evidence 0001213900-24-030055 |
| FY 2022 | $-17.1M | 2022-01-01 – 2022-12-31 | evidence 0001213900-23-023849 |
| FY 2021 | $65.0k | 2021-01-01 – 2021-12-31 | evidence 0001213900-22-014666 |
| FY 2020 | $-5.6M | 2020-01-01 – 2020-12-31 | evidence 0001213900-21-017883 |
| FY 2019 | $-7.6M | 2019-01-01 – 2019-12-31 | evidence 0001213900-21-017883 |
| FY 2018 | $-4.2M | 2018-01-01 – 2018-12-31 | evidence 0001213900-21-017883 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CollPlant Biotechnologies Ltd — all facts · Revenue · Net Income